GlycoMimetics Inc (GLYC)
0.2337
+0.03
(+13.72%)
USD |
NASDAQ |
Dec 20, 16:00
0.23
0.00 (0.00%)
After-Hours: 20:00
GlycoMimetics Total Assets (Quarterly): 15.70M for Sept. 30, 2024
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Biomarin Pharmaceutical Inc | 6.851B |
| Arbutus Biopharma Corp | 140.44M |
| Revance Therapeutics Inc | 461.56M |
| FibroGen Inc | 264.42M |
| Cidara Therapeutics Inc | 162.33M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 4.322M |
| Shareholders Equity (Quarterly) | 11.38M |